Hepatitis D virus (HDV) iRNA compositions and methods of use thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10640770
APP PUB NO 20170349901A1
SERIAL NO

15591558

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to RNAi agents, e.g., double-stranded RNAi agents, targeting the hepatitis D virus (HDV) genome, and methods of using such RNAi agents to inhibit expression of one or more HBV genes and methods of treating subjects having an HDV infection and/or HDV-associated disorder.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ALNYLAM PHARMACEUTICALS INC675 WEST KENDALL STREET HENRI A TERMEER SQUARE CAMBRIDGE MA 02142-1110

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hinkle, Gregory Cambridge, US 164 786
Jadhav, Vasant Sharon, US 64 697
Maier, Martin Belmont, US 260 4382
Manoharan, Muthiah Weston, US 491 18658
Milstein, Stuart Arlington, US 133 755
Rajeev, Kallanthottathil G Wayland, US 260 8660
Sepp-Lorenzino, Laura Jenkintown, US 18 148
Shulga, Morskaya Svetlana Sudbury, US 18 174
Xu, Huilei Boston, US 12 9

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Nov 5, 2027
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 5, 2031
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00